The Scientific Symposium “The First in the 21st Century. Innovations in Russian HIV treatment”, dedicated to the ...

On October 5, 2017 in St. Petersburg as part of the Second Forum on HIV, the Viriom company of ChemRar Group conducts a ...

On September 14–15, 2017 ChemRar Group presented their innovative developments at the Biotechmed-2017 conference in ...

On September 14, IPHARMA celebrated the fifth anniversary of the work in the market of clinical trials in the loft on ...

Conjugate, a company of ChemRar Group and the resident of the BioMedical Cluster of the Skolkovo Foundation, has ...

Moscow, June 24, 2017 — ELPIDA® (elsulfavirin), a new generation non-nucleoside reverse transcriptase inhibitor (NNRTI) ...

At the St. Petersburg International Economic Forum held at the site of ASI Boiling Point, Andrey Ivashchenko, the ...

On April 25, 2017 the Moscow Stadium Live concert hall hosted the final of GenerationS — the largest startup ...

On April 21, 2017 Skolkovo held the Fifth Skolkovo Robotics International Conference 2017, organized by the Skolkovo ...

  ChemRar Group (ChemRar) has announced a successful completion of a safety and tolerability trial of a ...

IPHARMA has maintained a leading position among contract research organizations in the volume of local drugs studies ...